Status:
COMPLETED
The Effect of Prophylactic FFP Administration on ECMO Circuit Longevity
Lead Sponsor:
Duke University
Conditions:
Extracorporeal Membrane Oxygenation
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the impact of scheduled fresh frozen plasma (FFP) administration on extracorporeal membrane oxygenation (ECMO) pump longevity in critically ill pediatric and neo...
Eligibility Criteria
Inclusion
- All patients \< 18 years receiving ECMO
Exclusion
- Planned withdrawal of life sustaining therapy in the next 48 hours
- Previous enrollment in the study
- Patients who cannot be consented within 48 hours
- Pregnant patients
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01903863
Start Date
July 1 2013
End Date
April 1 2016
Last Update
June 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center PICU and PCICU
Durham, North Carolina, United States, 27710